Vaxcyte, Inc. (PCVX)

63.56 -1.71 (-2.62%) USD  |  NASDAQ  |  Oct 16, 16:00
63.25 -0.31 (-0.49%) After-Hours: 17:43
More

Vaxcyte Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for PCVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Operating Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Revolution Medicines, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --